Clinical Trial Update: A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC [Phase 2]

View source ↗

Summary

A Phase 2 trial of MORF-057 in adults with moderately to severely active ulcerative colitis has posted results, and the study is currently not recruiting. This …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• MORF 057

Snippet

Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) | Conditions: Inflammatory Bowel Diseases, Colitis, Ulcerative | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-12-15